A healthy ecosystem supporting research and development of new anti-infectives is emerging with the considerable help of government efforts to address the threats of spreading antimicrobial resistance.
Twenty new antimicrobial products have come through FDA's Qualified Infectious Disease Products program and are in or preparing for Phase...